Total Payments
$11,989
2024 Payments
$1,893
Companies
52
Transactions
648
Medicare Patients
6,274
Medicare Billing
$409,226
Payment Breakdown by Category
Food & Beverage$9,615 (80.2%)
Other$2,250 (18.8%)
Education$124.30 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,615 | 644 | 80.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 1 | 18.8% |
| Education | $124.30 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,535 | 67 | $0 (2024) |
| Novo Nordisk Inc | $1,445 | 118 | $0 (2024) |
| Lilly USA, LLC | $959.54 | 82 | $0 (2024) |
| Amgen Inc. | $780.04 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $744.56 | 25 | $0 (2024) |
| PFIZER INC. | $560.18 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $557.73 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $335.33 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $303.47 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $224.74 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,893 | 104 | ABBVIE INC. ($456.54) |
| 2023 | $1,808 | 125 | AbbVie Inc. ($403.42) |
| 2022 | $3,698 | 89 | ABBVIE INC. ($2,593) |
| 2021 | $1,122 | 79 | Novo Nordisk Inc ($256.78) |
| 2020 | $664.64 | 47 | Novo Nordisk Inc ($134.80) |
| 2019 | $1,036 | 69 | Novo Nordisk Inc ($280.79) |
| 2018 | $1,088 | 75 | AstraZeneca Pharmaceuticals LP ($263.85) |
| 2017 | $680.53 | 60 | Lilly USA, LLC ($135.89) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 26 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/26/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Cardiovascular | ||||||
| 05/18/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/12/2017 | Lilly USA, LLC | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 05/10/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 05/09/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Diabetes | ||||||
| 04/13/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Central Nervous System (CNS) | ||||||
| 04/10/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: RESPIRATORY | ||||||
| 04/07/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Endocrinology | ||||||
| 04/03/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/27/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Diabetes | ||||||
| 03/02/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: Diabetes | ||||||
| 02/24/2017 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: PENNSAID | ||||||
| 02/16/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Migraine | ||||||
| 02/13/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Gout/Rheumatology | ||||||
| 02/09/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Diabetes | ||||||
| 01/26/2017 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Migraine | ||||||
| 01/23/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: DIABETES | ||||||
| 01/19/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Respiratory | ||||||
| 01/13/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/12/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Diabetes | ||||||
| 01/12/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,653 | 3,414 | $485,177 | $141,789 |
| 2022 | 18 | 1,654 | 2,212 | $260,961 | $104,132 |
| 2021 | 19 | 1,681 | 2,193 | $255,573 | $99,065 |
| 2020 | 14 | 1,286 | 1,639 | $189,236 | $64,240 |
Total Patients
6,274
Total Services
9,458
Medicare Billing
$409,226
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 368 | 630 | $228,690 | $48,061 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 305 | 305 | $113,460 | $36,420 | 32.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,140 | $47,880 | $21,029 | 43.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $16,020 | $10,111 | 63.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 382 | 701 | $4,907 | $4,809 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 122 | $31,232 | $4,593 | 14.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 51 | 51 | $3,927 | $3,848 | 98.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 19 | $11,077 | $2,856 | 25.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $7,125 | $2,173 | 30.5% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 15 | 15 | $5,895 | $1,927 | 32.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 57 | $1,995 | $1,618 | 81.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,400 | $1,135 | 81.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 16 | 16 | $1,920 | $605.44 | 31.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 14 | 14 | $686.00 | $529.76 | 77.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 47 | $1,927 | $468.45 | 24.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 36 | 38 | $912.00 | $361.76 | 39.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 36 | $1,440 | $335.68 | 23.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 19 | 20 | $1,342 | $255.52 | 19.0% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 12 | 12 | $882.00 | $156.57 | 17.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 13 | 13 | $1,245 | $116.48 | 9.4% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 19 | 19 | $266.00 | $116.09 | 43.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 19 | 19 | $247.00 | $96.52 | 39.1% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 12 | 12 | $480.00 | $83.92 | 17.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 37 | $222.00 | $81.40 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 278 | 278 | $68,944 | $34,016 | 49.3% |
About Dr. Christopher Connolly, M.D
Dr. Christopher Connolly, M.D is a Family Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881616167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Connolly, M.D has received a total of $11,989 in payments from pharmaceutical and medical device companies, with $1,893 received in 2024. These payments were reported across 648 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($9,615).
As a Medicare-enrolled provider, Connolly has provided services to 6,274 Medicare beneficiaries, totaling 9,458 services with total Medicare billing of $409,226. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Omaha, NE
- Active Since 07/24/2006
- Last Updated 12/09/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881616167
Products in Payments
- UBRELVY (Drug) $2,789
- Ozempic (Drug) $605.53
- QULIPTA (Drug) $472.29
- EVENITY (Biological) $375.29
- VRAYLAR (Drug) $354.16
- Kerendia (Drug) $303.47
- FARXIGA (Drug) $285.17
- Saxenda (Drug) $283.41
- NURTEC ODT (Drug) $246.77
- MOUNJARO (Drug) $241.60
- Prolastin-C Liquid (Biological) $223.66
- TRULICITY (Drug) $218.07
- TRELEGY ELLIPTA (Drug) $209.41
- EMGALITY (Drug) $191.40
- Vascepa (Drug) $188.17
- Prolia (Biological) $181.94
- PREVNAR 20 (Biological) $177.49
- Victoza (Drug) $177.39
- SYMBICORT (Drug) $172.62
- INVEGA SUSTENNA (Drug) $167.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Omaha
Dr. Gerard Stanley, M.d, M.D
Family Medicine — Payments: $49,779
Family Medicine $49,779
M. Dada, M.d., Ph.d, M.D., PH.D
Family Medicine — Payments: $14,443
Family Medicine $14,443
Dr. Yongge Liu, M.d, M.D
Family Medicine — Payments: $13,977
Family Medicine $13,977
Christopher Beasley, Pa-C, PA-C
Family Medicine — Payments: $11,635
Family Medicine $11,635
Joseph Dumba, M.d, M.D
Family Medicine — Payments: $10,949
Family Medicine $10,949
Dr. Ferdinando Andrade, M.d, M.D
Family Medicine — Payments: $10,854
Family Medicine $10,854